CRO leadership with implications such as:
o Predictable patient recruitment leading to evaluable data remaining a critical driver for successful study completion;
o Timely delivery of new products to market as a crucial driver of a pharmaceutical company's stock valuation;
o The significance of downsizing middle management, portfolio reduction and reallocation, and site initiation to developing and redeveloping countries.
"This unique forum will closely examine the compelling reasons for a paradigm shift in the strategic recruitment planning process, with a focus on how to move away from cost and quantity drivers to process, quality, training, and efficiency driven down through organizations from a strategic level," says Program Chairperson John Needham, Global Strategist and Chief Executive Officer, Needham and Company.
Sponsors, CROs, service providers, and clinical research team thought leaders will lead interactive group discussions to further crystallize the topics discussed in the more formal sessions.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
###
Read the full story at
Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Fluctuating eye pressure associated with visual field deterioration in glaucoma patients2.
Comparison of obstetric outcomes between on-call and patients own obstetricians3.
Vision restoration therapy shown to improve brain activity in brain injured patients4.
Diabetes appears to increase risk of death for patients with acute coronary syndromes5.
Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia6.
Restricting Blood Flow May Help Heart Bypass Patients7.
Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer8.
Study provides hope that some transplant patients could live free of antirejection drugs9.
Study provides hope that some transplant patients could live free of anti-rejection drugs10.
Longer ambulance journeys boost death risk for seriously ill patients11.
Expenses Overshadow Optimism for Kidney Failure Patients